Viral Assembly, Secretory Pathway, and Retroviral Life Cycles

Influenza Virus Machinery, Secretory Pathway, and Early Assembly

  • The virus packages the three components of its RNA-dependent RNA polymerase: PB1, PB2, and PA.
  • To reinitiate replication, the virus must recreate the original pattern of glycosylation on its surface glycoproteins. This involves maintenance of the glycan state through the glycosylation–folding–quality control cycle, including two rounds related to glucose processing in the ER quality-control system.
  • After reestablishing the proper glycosylation, the glycoproteins are ready to proceed through the secretory pathway.

ER Exit and Secretory Pathway Exit Routes

  • There are two main routes by which proteins exit the endoplasmic reticulum (ER):
    • Bulk flow (default ER-to-Golgi transport): cargo that accumulates in the ER can be packaged into vesicles for export.
    • COPII-mediated export with ER exit signals that target cargo into specialized vesicles.
  • Properly folded glycoproteins often form disulfide bonds (e.g., a proper “white bond” in the transcript; intended as a disulfide bond) and are then packaged for delivery to the Golgi apparatus.
  • The vesicles contain v-SNAREs (V-SNARE) on the vesicle membrane and t-SNAREs (T-SNARE) on the target membrane (cis-Golgi or ER exit site). Docking requires SNARE pairing: V-SNAREs + T-SNAREs.
  • SNARE complex formation brings the vesicle to the target membrane and facilitates fusion once tethered.
  • The complex requires additional components: Rab-family GTPases (Rab) to regulate docking/tethering, tethering factors (e.g., tethering proteins), and NSF with α-SNAP for SNARE complex disassembly and SNARE recycling after fusion.

Vesicle Docking, Fusion, and Early Golgi Routing

  • The vesicle docking/fusion apparatus includes: V-SNARE, T-SNARE, Rab GTPases, tethering factors, NSF, and α-SNAP.
  • Once docking/fusion occurs, the vesicle content is delivered to the cis-Golgi network, and trafficking proceeds toward the trans-Golgi network (TGN).
  • Activation of Rab GTPases (Rab-GTP) regulates subsequent steps, including stable tethering and fusion events.
  • Hydrolysis of GTP to GDP (Rab-GTP to Rab-GDP) is triggered by GTPase-activating proteins (GAPs); this hydrolysis leads to progression of vesicle fusion and release of tethering factors.
  • The NSF–α-SNAP complex disassembles the cisternae SNARE complex, enabling SNARE components to be recycled for new rounds of vesicle fusion.

Golgi Processing and Hemagglutinin (HA) Maturation in Influenza

  • As cargo moves through the Golgi stacks, complex glycosylation and processing of glycans occur; the HA0 precursor undergoes maturation steps involving glycosylation changes and eventual proteolytic cleavage.
  • In influenza, HA0 (the uncleaved form) is cleaved into HA1 and HA2 by host proteases, enabling a mature adhesive (viral binding) glycoprotein prepared for fusion.
  • The HA glycoprotein harbors glycan modifications as it traverses the Golgi; these N-linked modifications continue through the Golgi stacks.
  • The HA0 to HA1/HA2 cleavage is essential for functional viral fusion activity and proper maturation of the envelope glycoprotein.

Viral Assembly at the Plasma Membrane and Genome Packaging

  • After maturation, envelope proteins are localized to the cell membrane to assemble the viral envelope.
  • The eight influenza genome segments are exported to the cytosol via the viral RNA polymerase complex and are packaged into budding virions. These segments are subsequently encapsidated into new viral particles for assembly.
  • Importantly, many virions do not package all eight segments perfectly; most virus particles produced in a given cell will be missing at least one genomic segment, reflecting the random nature of packaging. This is consistent with the slide note: the process is probabilistic rather than deterministic.
  • The RNA-dependent RNA polymerase (RDRP) of influenza is highly error-prone, leading to frequent mutations and variation in progeny virions, contributing to viral diversity and immune escape.
  • As a result, the progeny population exhibits variation in adhesion and surface proteins, enabling rapid adaptation and frequent seasonal epidemics.

Host Antiviral Responses and Viral Countermeasures in Transcription/Translation

  • Host antiviral responses rely on multiple pathways to detect and respond to viral RNA transcription.
  • The virus employs strategies to subvert host responses and permit continued transcription/translation of viral transcripts, including mechanisms that inhibit host translation or alter transcriptional regulation.
  • The high mutation rate of influenza’s polymerase contributes to rapid antigenic drift, complicating immune recognition and vaccine design.

HIV and Retroviruses: Structure, Lifecycle, and Oncogenesis

  • HIV envelope components:
    • SU: gp120 (surface unit)
    • TM: gp41 (transmembrane unit) with a fusion peptide; these components mediate attachment and membrane fusion.
  • The retroviral genome uses reverse transcription to convert RNA into DNA, which integrates into the host genome. Integration occurs somewhat randomly across host chromosomes rather than at a fixed site.
  • Retroviruses can activate host oncogenes through integration near regulatory regions, contributing to oncogenesis (an example is Rous sarcoma virus, which caused cancer by activating cellular genes).
  • Retroviruses do not strictly require a nonpermissive host for integration, and their ability to integrate can lead to varied outcomes, including potential oncogenesis.

Emergence of HIV and Historical/Ethical Context

  • HIV emerged as a human pathogen in the late 20th century, believed to have crossed from nonhuman primates (SIV) to humans in Sub-Saharan Africa via zoonotic transfer.
  • The discovery and attribution of HIV’s isolation and characterization included notable ethical controversies, including disputes over sole credit for discovery. A well-known historical discussion involves debates about recognition between competing research groups and figures.
  • HBO produced a documentary exploring the HIV story and related historical context.

HIV Pathogenesis: Latency, Transmission, and Cytopathic Effects

  • HIV infection in CD4+ T cells leads to a progressive decline in immune competence. A single infected cell can fuse with up to about 500 uninfected cells, contributing to widespread cytopathic effects.
  • It is estimated that infection of as few as 0.02%0.02\% of circulating CD4+ T cells can be sufficient to compromise the entire T-cell population, undermining immune function.
  • Early in infection, HIV can establish a latent reservoir in which viral replication is minimal or undetectable, delaying disease progression. Latency duration is highly variable and can range from as short as 6 months6\text{ months} to as long as 10 years10\text{ years} without antiretroviral therapy.
  • Mortality during HIV infection is driven largely by opportunistic infections and other secondary infections during the latency or later stages, rather than direct cytopathic death alone.
  • The latency period and the variable course of infection underscore the heterogeneity of HIV disease progression and the public health importance of early detection and treatment.

Real-World Relevance and Context

  • The described processes connect molecular events inside the infected cell (glycosylation, SNARE-mediated trafficking, Golgi processing) with macroscopic outcomes (viral envelope formation, genome packaging, and viral spread).
  • Understanding the balance between viral replication fidelity (high mutation rate) and host defenses illuminates why certain viruses exhibit rapid evolution and seasonal epidemics (influenza) and why others persist as latent infections (HIV).
  • Historical and ethical considerations around discovery, credit, and the social impact of viruses provide important context for scientific practice and public health policy.

Key Takeaways and Connections

  • Viral replication and assembly rely on host cell machinery (ER, Golgi, vesicle trafficking, SNAREs, Rab GTPases, NSF/α-SNAP) to produce an enveloped virion.
  • Glycosylation patterns and proteolytic maturation (e.g., HA0 cleavage in influenza) are critical for infectivity and fusion competence.
  • Packaging of segmented genomes can be probabilistic and incomplete, yet the resulting diversity fuels immune escape and epidemic waves.
  • Retroviruses disrupt host cells through integration, potential oncogene activation, and latency, demonstrating distinct pathogenic strategies from orthomyxoviruses like influenza.
  • Ethical considerations and historical context are integral to understanding the development of HIV research and the broader narrative of emerging infectious diseases.

Mathematical and Numerical Highlights (LaTeX Used)

  • Number of influenza genome segments: 88
  • Fraction of infected circulating cells associated with debilitation in the discussed scenario: 0.02%=2×10−40.02\% = 2 \times 10^{-4}
  • Latency duration range: [6 months,10 years][6\text{ months}, 10\text{ years}]
  • Possible maximum infectious spread from a single infected cell described: up to 500500 fused/uninfected cells
  • Rounding and transcription/replication processes referenced as “two rounds”: 22
  • General notion of random integration: no single fixed chromosomal target for retroviral integration (random distribution across host genome)